1. Persistence of DNA from canine parvovirus modified-live virus in canine tissues
- Author
-
Giorgia Schirò, Francesco Mira, Nicola Decaro, Costantina Desario, Gabriele Chiaramonte, Santina Di Bella, Vincenza Cannella, Giuseppa Purpari, Gianluca Ventriglia, Vincenzo Randazzo, Domenico Vicari, Francesca Gucciardi, Calogero Castronovo, and Annalisa Guercio
- Subjects
General Veterinary ,General Medicine - Abstract
Canine parvovirus (CPV-2) modified-live virus vaccine strain can replicate in lymphoid tissues and intestinal mucosa after administration, being shed through canine faeces. Detection of vaccine strains has been reported in the bloodstream and faeces, potentially interfering with molecular diagnostic tests. The persistence of these strains in canine tissues has not yet been described. With this aim, canine tissues were tested during a molecular survey to screen for the presence of canine enteric viruses. Tissue samples from 165 dead dogs were tested by a conventional PCR assay. Positive samples and five commercial vaccines were subjected to sequence analysis. Vaccinal strains were detected and virus load was measured by using a set of real-time PCR assays using minor-groove binder (MGB) probes. Seventy-five dogs (45.4%) tested positive for CPV-2. Strains from 70 dogs were characterised as field variants. The presence of CPV sequences of vaccine origin was observed in the spleen, intestine, and mesenteric lymph nodes of five young dogs. Vaccinal strains were detected from 12 to 24 days after the last vaccine administration. Viral loads comprised between 6.3 × 10
- Published
- 2022
- Full Text
- View/download PDF